Sarah Ketterer
AZN icon

Sarah Ketterer’s AstraZeneca AZN Stock Holding History

Sarah Ketterer’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.8B Buy
11,024,422
+1,667,032
+18% +$278M 20.2% 1
2026
Q2 		$1.75B Buy
9,357,390
+1,935,641
+26% +$364M 18.97% 1
2026
Q1 		$1.44B Buy
7,421,749
+6,916,300
+1,368% +$1.33B 17.66% 1
2025
Q4 		$92.9M Sell
505,449
-28,237
-5% -$4.95M 1.28% 14
2025
Q3 		$81.9M Buy
533,686
+56,962
+12% +$8.62M 1.08% 16
2025
Q2 		$66.6M Buy
476,724
+47,780
+11% +$6.7M 1.05% 16
2025
Q1 		$63.1M Buy
428,944
+13,009
+3% +$1.88M 1.32% 18
2024
Q4 		$54.5M Buy
415,935
+170,715
+70% +$23.9M 1.24% 20
2024
Q3 		$38.2M Buy
245,220
+19,926
+9% +$3.22M 0.94% 33
2024
Q2 		$35.1M Sell
225,294
-22,944
-9% -$3.45M 0.96% 36
2024
Q1 		$33.6M Buy
248,238
+17,877
+8% +$2.37M 0.88% 36
2023
Q4 		$31M Buy
230,361
+52,750
+30% +$6.86M 0.79% 40
2023
Q3 		$24.1M Buy
177,611
+45,438
+34% +$6.21M 0.63% 42
2023
Q2 		$18.9M Sell
132,173
-29,679
-18% -$4.37M 0.5% 48
2023
Q1 		$22.5M Buy
161,852
+17,542
+12% +$2.36M 0.54% 36
2022
Q4 		$19.6M Sell
144,310
-7,997
-5% -$1M 0.57% 45
2022
Q3 		$16.7M Sell
152,307
-14,642
-9% -$1.86M 0.47% 49
2022
Q2 		$22.1M Sell
166,949
-37,129
-18% -$4.87M 0.55% 41
2022
Q1 		$27.1M Buy
204,078
+38,842
+24% +$4.66M 0.65% 39
2021
Q4 		$19.2M Sell
165,236
-8,270
-5% -$973K 0.42% 49
2021
Q3 		$20.8M Buy
173,506
+88,614
+104% +$10.3M 0.47% 49
2021
Q2 		$10.2M Buy
+84,892
New +$9.31M 0.21% 67

Other funds holding AZN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $162B AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Sarah Ketterer's AZN Position: Q3 2026 in Review

Sarah Ketterer increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $278M and bringing the position to 11,024,422 shares worth $1.8B. The position accounts for 20.2% of the portfolio, ranked #1.

Sarah Ketterer first reported a position in AZN in Q2 2021 and has held it in 22 quarters since. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Sarah Ketterer held 11,024,422 shares of AstraZeneca worth $1.8B as of Q3 2026.
  • Sarah Ketterer bought 1,667,032 AstraZeneca shares in Q3 2026, an estimated $278M.
  • AstraZeneca made up 20.2% of Sarah Ketterer's portfolio in Q3 2026, its #1 holding.
  • Sarah Ketterer first reported a position in AstraZeneca in Q2 2021 and has held it in 22 quarters since.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.